Rrad-flox Mouse
Common Name
Rrad-flox
제품 ID
S-CKO-12098
Backgroud
C57BL/6JCya
품종 계통계통 ID
CKOCMP-56437-Rrad-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Rrad-flox Mouse (카탈로그 번호 S-CKO-12098)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Rrad-flox
품종 계통계통 ID
CKOCMP-56437-Rrad-B6J-VA
유전자명
제품 ID
S-CKO-12098
유전자 별칭
Rad, REM3
배경
C57BL/6JCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 8
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000034351
NCBI 전사체 ID
NM_019662
타겟 영역
Exon 3~5
유효 영역 크기
~1.8 kb
유전자 연구 개요
RRAD, short for Ras-related associated with diabetes, is a member of the Ras-related GTPase superfamily. Primarily a cytosolic protein that activates in the plasma membrane, it is highly expressed in type 2 diabetes patients and serves as a biomarker for congestive heart failure. RRAD is involved in multiple cellular activities such as cell division, motility, apoptosis, and energy metabolism, by modulating tumor-related gene expression and interacting with downstream effectors [1].
In cancer, RRAD shows dual roles. In gastric and colorectal cancer, its inhibition via siRNA/shRNA led to decreased tumor cell proliferation in vitro and in vivo, along with reduced cell invasion, decreased EMT markers, angiogenesis, and associated proteins like VEGF and ANGP2, suggesting it could be a therapeutic target [2]. In papillary thyroid cancer, the NEAT1_2/RRAD/EHF positive feedback loop facilitated aerobic glycolysis [3]. In hepatocellular carcinoma, RRAD suppressed the Warburg effect by downregulating ACTG1, reducing cell proliferation, arresting the cell cycle, and increasing apoptosis [4]. In lung cancer, it inhibited the Warburg effect through negative regulation of the NF-κB signaling [5]. In contrast, in malignant glioblastoma, RRAD promoted EGFR-mediated STAT3 activation and temozolomide resistance [6]. In pancreatic cancer, SETD8 inhibited ferroptosis by inhibiting RRAD expression [7]. In oral squamous cell carcinoma, downregulation of RRAD in the tumor margin enhanced energy metabolism and tumor progression [8]. Also, RRAD was identified as a marker and negative regulator of cellular senescence, with its up-regulation countering cellular senescence by reducing reactive oxygen species levels [9].
In conclusion, RRAD is a multifunctional gene involved in various biological processes and diseases, especially cancer. Its dual role as either an oncogene or tumor suppressor depending on the cancer type highlights its complexity. Studies on RRAD using gene-knockout or conditional-knockout models (although not specifically detailed in the given references) could potentially further clarify its role in these biological processes and disease conditions, providing insights for targeted therapies.
References:
1. Sun, Zhangyue, Li, Yongkang, Tan, Xiaolu, Xu, Liyan, Long, Lin. 2023. Friend or Foe: Regulation, Downstream Effectors of RRAD in Cancer. In Biomolecules, 13, . doi:10.3390/biom13030477. https://pubmed.ncbi.nlm.nih.gov/36979412/
2. Kim, Hee Kyung, Lee, Inkyoung, Kim, Seung Tae, Park, Joon Oh, Kang, Won Ki. 2019. RRAD expression in gastric and colorectal cancer with peritoneal carcinomatosis. In Scientific reports, 9, 19439. doi:10.1038/s41598-019-55767-7. https://pubmed.ncbi.nlm.nih.gov/31857616/
3. Sun, Wei, Wang, Zhiyuan, Qin, Yuan, He, Liang, Zhang, Hao. . NEAT1_2/RRAD/EHF Positive Feedback Loop Facilitates Aerobic Glycolysis in Papillary Thyroid Cancer Cells. In Endocrinology, 164, . doi:10.1210/endocr/bqad085. https://pubmed.ncbi.nlm.nih.gov/37279586/
4. Yan, Yingcai, Xu, Hao, Zhang, Linshi, Ge, Wenhao, Wang, Weilin. 2019. RRAD suppresses the Warburg effect by downregulating ACTG1 in hepatocellular carcinoma. In OncoTargets and therapy, 12, 1691-1703. doi:10.2147/OTT.S197844. https://pubmed.ncbi.nlm.nih.gov/30881024/
5. Liu, Juan, Zhang, Cen, Wu, Rui, Yang, Bo, Feng, Zhaohui. . RRAD inhibits the Warburg effect through negative regulation of the NF-κB signaling. In Oncotarget, 6, 14982-92. doi:. https://pubmed.ncbi.nlm.nih.gov/25893381/
6. Yeom, Seon-Yong, Nam, Do-Hyun, Park, Chaehwa. 2014. RRAD promotes EGFR-mediated STAT3 activation and induces temozolomide resistance of malignant glioblastoma. In Molecular cancer therapeutics, 13, 3049-61. doi:10.1158/1535-7163.MCT-14-0244. https://pubmed.ncbi.nlm.nih.gov/25313011/
7. Lu, Zekun, Hu, Qiangsheng, Qin, Yi, Xu, Xiaowu, Chen, Xuemin. 2023. SETD8 inhibits ferroptosis in pancreatic cancer by inhibiting the expression of RRAD. In Cancer cell international, 23, 50. doi:10.1186/s12935-023-02899-6. https://pubmed.ncbi.nlm.nih.gov/36934248/
8. Cheng, Aoming, Xu, Qiaoshi, Li, Bo, Han, Zhengxue, Feng, Zhien. 2024. The enhanced energy metabolism in the tumor margin mediated by RRAD promotes the progression of oral squamous cell carcinoma. In Cell death & disease, 15, 376. doi:10.1038/s41419-024-06759-7. https://pubmed.ncbi.nlm.nih.gov/38811531/
9. Wei, Zhao, Guo, Haiyang, Qin, Junchao, Gong, Yaoqin, Shao, Changshun. 2018. Pan-senescence transcriptome analysis identified RRAD as a marker and negative regulator of cellular senescence. In Free radical biology & medicine, 130, 267-277. doi:10.1016/j.freeradbiomed.2018.10.457. https://pubmed.ncbi.nlm.nih.gov/30391675/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
